title: Four-year follow-up study in a NF1 boy with a focal pontine hamartoma.
abstract: Neurofibromatosis is a collective name for a group of genetic conditions in which benign tumours affect the nervous system. Type 1 is caused by a genetic mutation in the NF1 gene (OMIM 613113) and symptoms can vary dramatically between individuals, even within the same family. Some people have very mild skin changes, whereas others suffer severe medical complications. The condition usually appears in childhood and is diagnosed if two of the following are present: six or more café-au-lait patches larger than 1.5 cm in diameter, axillary or groin freckling, 2 or more Lisch nodules (small pigmented areas in the iris of the eye), 2 or more neurofibromas, optic pathway gliomas, bone dysplasia, and a first-degree family relative with Neurofibromatosis type 1. The pattern of inheritance is autosomal dominant, however, half of all NF1 cases are 'sporadic' and there is no family history. Neurofibromatosis type 1 is an extremely variable condition whose morbidity and mortality is largely dictated by the occurrence of the many complications that may involve any of the body systems. We describe a family affected by NF1 in whom genetic molecular analysis identified the same mutation in the son and father. Routine MRI showed pontine focal lesions in the eight-year-old son, though not in the father. We performed a four years follow-up study and at follow-up pontine hamartoma size remained unchanged in the son, and the father showed still no brain lesions, confirming thus an intra-familial phenotype variability.
authors: Child Neurology, Chair of Paediatrics, NESMOS Department, Faculty of Medicine and Psychology, Sapienza University c/o St Andrea Hospital, Via di Grottarossa 1035-1039, 00189, Rome, Italy. pasquale.parisi@uniroma1.it
authors: Pasquale
authors: P
authors: Parisi
authors: Severino
authors: S
authors: Persechino
authors: Maria Chiara
authors: MC
authors: Paolino
authors: Francesco
authors: F
authors: Nicita
authors: Isabella
authors: I
authors: Torrente
authors: Alessandro
authors: A
authors: Bozzao
authors: Maria Pia
authors: MP
authors: Villa
mesh_terms: D015415:Biomarkers / Q000097:blood; D002648:Child; D005220:Fathers; D005500:Follow-Up Studies; D016514:Genes, Neurofibromatosis 1; D005820:Genetic Testing; D006222:Hamartoma / Q000235:genetics*; D006801:Humans; D008297:Male; D009154:Mutation; D009456:Neurofibromatosis 1 / Q000235:genetics*; D025542:Neurofibromin 1 / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D011149:Pons
chemical_list: D015415:Biomarkers; D025542:Neurofibromin 1
references: Eur J Paediatr Neurol. 2012 Jan;16(1):42-7
references: 22088602
references: Brain. 2003 Jan;126(Pt 1):152-60
references: 12477702
references: Neuroradiology. 2001 Jan;43(1):62-7
references: 11214651
references: Pediatrics. 1999 Oct;104(4):e49
references: 10506274
references: Radiology. 2001 May;219(2):354-8
references: 11323456
references: Neurosurgery. 2007 Oct;61(4):762-6; discussion 766-7
references: 17986937
references: Am J Med Genet. 1999 Mar 26;89(1):38-44
references: 10469435
references: Eur J Radiol. 2005 Nov;56(2):229-34
references: 15963674
references: Cancer Genet Cytogenet. 2006 Mar;165(2):167-71
references: 16527612
references: Electrophoresis. 2000 Feb;21(3):541-4
references: 10726756
references: AJNR Am J Neuroradiol. 2007 Apr;28(4):773-6
references: 17416837
references: AJNR Am J Neuroradiol. 1999 Oct;20(9):1619-27
references: 10543631
references: Acta Neurol Taiwan. 2007 Jun;16(2):68-73
references: 17685129
references: AJNR Am J Neuroradiol. 1995 Jan;16(1):141-7
references: 7900583
references: Pediatr Radiol. 2012 Apr;42(4):449-54
references: 22033857
references: Childs Nerv Syst. 1999 Jul;15(6-7):295-308
references: 10461778